CO4410253A1 - TARGET CYTOLYSIS OF HIV INFECTED CELLS BY CELLS CARRYING THE CHEMICAL CD4 RECEPTOR - Google Patents

TARGET CYTOLYSIS OF HIV INFECTED CELLS BY CELLS CARRYING THE CHEMICAL CD4 RECEPTOR

Info

Publication number
CO4410253A1
CO4410253A1 CO95034525A CO95034525A CO4410253A1 CO 4410253 A1 CO4410253 A1 CO 4410253A1 CO 95034525 A CO95034525 A CO 95034525A CO 95034525 A CO95034525 A CO 95034525A CO 4410253 A1 CO4410253 A1 CO 4410253A1
Authority
CO
Colombia
Prior art keywords
chemical
hiv
membrane
receptor
cell infected
Prior art date
Application number
CO95034525A
Other languages
Spanish (es)
Inventor
Brian Seed
Banapour Babak
Charles Romeo
Kolanus Waldemar
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/284,391 external-priority patent/US5851828A/en
Priority claimed from US08/394,388 external-priority patent/US6753162B1/en
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of CO4410253A1 publication Critical patent/CO4410253A1/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1. UN METODO PARA TRATAR EL HIV EN MAMIFEROS, DI- CHO METODO COMPRENDE ADMINISTRAR A DICHO MAMIFERO UNA CANTIDAD EFECTIVA DE CELULAS TERAPEUTICAS, DICHAS CELULAS TERAPEUTICAS EXPRESA UN LIMITE- MEMBRANA, RECEPTOR QUIMERICO PROTEINACEO QUE COM- PRENDE UNA PORCION EXTRACELULAR QUE INCLUYE UN FRAGMENTO DE CD4 QUE ES CAPAZ DE RECNOCER SIGNIFI- CATIVAMENTE Y LIGAR DICHA CELULA INFECTADA POR HIV PERO QUE NO MEDIA LA INFECCION HIV. 9. UNA CELULA QUE EXPRESA UN RECEPTOR QUIMERICO DE LIMITE-MEMBRANA PROTEINACEO COMPRENDE UNA PORCION EXTRACELULAR QUE INCLUYE UN FRAGMENTO DE CD4 QUE ES CAPAZ DE RECONOCER ESPECIFICAMENTE Y LIGAR UNA CELULA INFECTADA POR HIV PERO QUE NO MEDIA LA IN- FECCION HIV. 16. UN RECEPTOR DE QUIMERA PROTEINACEO DE LIMITE- MEMBRANA COMPRENDE UNA PORCION EXTRACELULAR QUE INCLUYE UN FRAGMENTO DE CD4 QUE ES CAPAZ DE RECO- NOCER ESPECIFICAMENTE Y LIGAR UNA CELULA INFECTADA POR HIV PERO QUE NO MEDIA LA INFECCION HIV. 22. UN DNA QUE CODIFICA UN RECEPTOR QUIMERICO PROTEINACEO DE LIMITE-MEMBRANA COMPRENDE UNA POR- CION EXTRACELULAR QUE INCLUYE UN FRAGMENTO DE CD4 QUE ES CAPAZ DE ESPECIFICAMENTE RECONOCER Y LIGAR UNA CELULA INFECTADA POR HIV PERO QUE NO MEDIA LA INFECCION HIV. 23. UN SECTOR QUE COMPRENDE UN RECEPTOR QUIMERICO DE DNA DE LA REIVINDICACION 22.1. A METHOD FOR TREATING HIV IN MAMMALS, SUCH A METHOD INCLUDES ADMINISTERING AN EFFECTIVE AMOUNT OF THERAPEUTIC CELLS, SUCH TREATMENT CELLS EXPRESS A LIMIT- MEMBRANE, PROVIDES A CHEMICAL RECEIVER THAT PROVIDES A PROTEIN OF CD4 THAT IS ABLE TO RECOGNIZE SIGNIFICANTLY AND LINK TO SUCH CELL INFECTED BY HIV BUT IT DOES NOT MEAN HIV INFECTION. 9. A CELL THAT EXPRESSES A PROTEINACEO CHEMICAL LIMIT-MEMBRANE RECEPTOR INCLUDES AN EXTRACELLULAR PORTION THAT INCLUDES A CD4 FRAGMENT THAT IS ABLE TO RECOGNIZE SPECIFICALLY AND LINK A CELL INFECTED WITH HIV BUT IT DOES NOT MEASURE HIV INFECTION. 16. A CHEMICAL LIMIT MEMBRANE PROTEINACEO RECEIVER UNDERSTANDS AN EXTRACELLULAR PORTION THAT INCLUDES A CD4 FRAGMENT THAT IS ABLE TO RECOGNIZE SPECIFICALLY AND LINK A CELL INFECTED WITH HIV BUT NOT MEDIATING HIV INFECTION. 22. DNA CODING A MEMBRANE-PROTEINACEO CHEMICAL RECEPTOR INCLUDES AN EXTRACELLULAR PORTION THAT INCLUDES A CD4 FRAGMENT THAT IS CAPABLE OF SPECIFICALLY RECOGNIZING AND LINKING A CELL INFECTED WITH HIV BUT NOT MEDIATING HIV INFECTION. 23. A SECTOR THAT INCLUDES A CHEMICAL DNA RECEIVER OF CLAIM 22.

CO95034525A 1994-08-02 1995-08-02 TARGET CYTOLYSIS OF HIV INFECTED CELLS BY CELLS CARRYING THE CHEMICAL CD4 RECEPTOR CO4410253A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/284,391 US5851828A (en) 1991-03-07 1994-08-02 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US08/394,388 US6753162B1 (en) 1991-03-07 1995-02-24 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells

Publications (1)

Publication Number Publication Date
CO4410253A1 true CO4410253A1 (en) 1997-01-09

Family

ID=23558758

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95034525A CO4410253A1 (en) 1994-08-02 1995-08-02 TARGET CYTOLYSIS OF HIV INFECTED CELLS BY CELLS CARRYING THE CHEMICAL CD4 RECEPTOR

Country Status (2)

Country Link
CO (1) CO4410253A1 (en)
RU (1) RU2165703C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2465324C1 (en) * 2011-06-16 2012-10-27 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт клинической иммунологии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИКИ" СО РАМН) Method for generation of specific immune response on human immunodeficiency virus antigens

Also Published As

Publication number Publication date
RU2165703C2 (en) 2001-04-27

Similar Documents

Publication Publication Date Title
FI963150A0 (en) Targeted cytolysis of HIV-infected cells by cells containing the chimeric CD4 receptor
TR199902426T2 (en) Control of plant pests.
AR042378A2 (en) MAPACHE RECOMBINANT POXVIRUS, VACCINE FOR USE IN CATS AND USE OF SUCH POXVIRUS TO PREPARE AN EFFECTIVE VACCINE AGAINST INFECTION OF THE FELINE IMMUNODEFICIENCY VIRUS
BR9815761A (en) Vacuum process for the manufacture of siloxane-oxyalkylene copolymers
DK0766330T3 (en) Ingredients for use in electrochemical cells and their use in oxygen separation
ES2134770T3 (en) PROTEINS PRODUCED BY HUMAN LYMPHOCYTES, CODANT DNA SEQUENCE FOR THESE PROTEINS AND PHARMACEUTICAL AND BIOLOGICAL APPLICATIONS.
NZ334450A (en) Apparatus and methods for active biological sample preparation
DE69637147D1 (en) TRANSPORT PROTEINS AND ITS USES
DE69632536D1 (en) VACCINALS FOR THE RESPIRATORY SYNCYTIAL VIRUS WITH NUCLEIC ACIDS
ES2109924T3 (en) RAPID, VERSATILE AND SIMPLE METHOD OF EXPRESSION OF GENES IN EUCARYTIC CELLS.
AR245684A1 (en) Improved hydrogenolysis/dehydrohalogenation process
DE69129034D1 (en) MOLECULAR CLONES OF HIV-1 AND THEIR USE
AR002742A1 (en) ADIPOSE TYPE REGULATORY PROTEIN, PROCEDURE TO PRODUCE SUCH PROTEIN, PHARMACEUTICAL FORMULATIONS INCLUDING IT, ISOLATED DNA MOLECULES THAT CODES SUCH PROTEIN, VECTOR AND RECOMBINANT CELLS THAT INCLUDE SUCH DNA
CO4410253A1 (en) TARGET CYTOLYSIS OF HIV INFECTED CELLS BY CELLS CARRYING THE CHEMICAL CD4 RECEPTOR
FI970428A (en) Cells with CD4-attracting receptors and related molecules and methods
DE58906338D1 (en) Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and their use in drugs.
DE69502599T2 (en) POROUS METAL COMPOSITE BODY
ES2099678B1 (en) PROCEDURE FOR THE INACTIVATION OF VIRUSES IN PROTEINS.
DK0852623T3 (en) Nucleic acid molecules encoding proteins that mediate the adhesion of Neisseria cells to human cells
PT859613E (en) UTILIZATION OF FLUPIRTIN FOR PROPHYLAXIS AND THE TREATMENT OF DISEASES ASSOCIATED WITH AN ALTERATION OF THE HEMATOPOIETIC CELL SYSTEM
ES2147200T3 (en) USE OF A POISON OF HYMENOPTERS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT DNA VIRUS INFECTIONS.
DE69502934T2 (en) SENSOR DEVICE
DE59611293D1 (en) PROTEIN WITH DNASE ACTIVITY
WO2000061613A3 (en) Channel forming toxins as antiviral agents
AR001321A1 (en) Novel toxins.